Log In
Print
BCIQ
Print
Print this Print this
 

memantine ER/donepezil (Namzaric) (ADS-8704, MDX-8704)

Also known as: Arimenda

  Manage Alerts
Collapse Summary General Information
Company Adamas Pharmaceuticals Inc.
DescriptionOnce-daily, fixed-dose combination of memantine ER, a NMDA receptor antagonist, and donepezil, an acetylcholinesterase (AChE) inhibitor
Molecular Target NMDA receptor ; Acetylcholinesterase (AChE)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentApproved
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat moderate to severe Alzheimer's dementia
Regulatory Designation

Partner

Actavis plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today